Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IN › HAMMOND › ALVERNO LABORATORIES, LLC

ALVERNO LABORATORIES, LLC

NPI: 1861763658 · HAMMOND, IN 46324 · Clinical Medical Laboratory · NPI assigned 01/25/2012

$33.87M
Total Medicaid Paid
2,625,084
Total Claims
2,307,087
Beneficiaries
241
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTERESE, SAM (CEO AND PRESIDENT)
NPI Enumeration Date01/25/2012

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 262,300 $2.07M
2019 301,869 $4.14M
2020 310,248 $4.21M
2021 413,588 $6.40M
2022 507,520 $6.90M
2023 480,681 $6.00M
2024 348,878 $4.15M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 34,285 29,211 $2.32M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 59,234 52,496 $2.03M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 58,606 52,696 $2.01M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 36,893 32,671 $1.97M
84443 Thyroid stimulating hormone (TSH) 140,776 125,381 $1.79M
80053 Comprehensive metabolic panel 214,797 187,431 $1.63M
80050 General health panel 33,033 30,846 $1.44M
80061 Lipid panel 179,315 157,306 $1.11M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 84,132 73,040 $1.11M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 24,046 19,997 $1.05M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 216,833 187,916 $1.02M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 22,913 18,598 $917K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 51,936 47,892 $900K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 28,783 26,404 $732K
83036 Hemoglobin; glycosylated (A1C) 111,658 99,071 $623K
87086 Culture, bacterial; quantitative colony count, urine 79,660 71,499 $542K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 6,018 5,596 $541K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 24,469 22,331 $539K
36415 Collection of venous blood by venipuncture 153,335 134,121 $466K
82607 45,529 38,899 $449K
87480 24,027 22,144 $437K
87510 23,986 22,119 $436K
86235 3,871 3,234 $374K
87660 24,400 22,462 $369K
80081 6,593 5,917 $366K
86780 25,770 22,731 $347K
84439 46,791 40,948 $316K
88305 Level IV - Surgical pathology, gross and microscopic examination 10,470 9,399 $307K
86480 6,822 6,134 $300K
86803 21,441 18,629 $283K
86003 6,771 5,116 $278K
87481 6,537 3,489 $261K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 925 792 $254K
87186 28,955 25,739 $237K
80074 7,133 6,368 $227K
81514 2,405 2,235 $220K
82728 26,540 23,127 $201K
84153 14,405 12,680 $171K
80048 Basic metabolic panel (calcium, ionized) 30,434 26,917 $157K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 5,269 4,198 $146K
82570 39,625 35,471 $143K
87081 26,274 24,536 $134K
87536 2,182 1,984 $133K
87070 21,910 19,999 $125K
83550 19,461 17,135 $122K
81001 55,151 47,493 $122K
83970 5,166 4,659 $120K
82043 34,442 30,864 $119K
83540 25,288 22,244 $119K
84403 5,528 4,894 $112K
86481 2,165 2,043 $109K
82746 10,945 9,514 $103K
83001 6,630 5,712 $100K
87340 9,863 8,679 $96K
87522 Neg quan hep c or qual rna 2,600 2,314 $94K
84702 10,438 7,970 $88K
87077 14,749 13,407 $79K
84481 8,106 7,042 $78K
85027 16,752 15,314 $76K
85651 23,949 20,534 $75K
83735 17,288 13,303 $73K
86038 6,352 5,540 $72K
86696 4,152 3,676 $66K
83655 6,648 6,089 $66K
84146 5,197 4,562 $65K
86140 17,559 15,172 $61K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,047 965 $61K
88342 1,771 1,590 $60K
87088 8,248 7,385 $57K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 5,437 4,812 $57K
86769 1,565 1,260 $56K
86695 4,415 3,871 $51K
84550 15,446 13,196 $50K
86706 4,798 4,246 $49K
86360 1,613 1,492 $49K
86376 5,334 4,643 $48K
86787 3,753 3,258 $46K
83002 4,641 3,941 $45K
83880 2,627 2,267 $45K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,105 908 $44K
86225 4,571 3,941 $44K
82785 4,865 3,889 $40K
86431 7,670 6,724 $39K
86359 1,623 1,499 $37K
82670 2,532 2,208 $36K
84270 2,303 2,069 $36K
80076 6,351 5,739 $36K
86762 4,186 3,701 $35K
86800 3,224 2,804 $34K
87529 772 685 $34K
87581 993 849 $34K
87486 988 845 $34K
81003 19,599 16,914 $33K
84144 2,607 2,127 $32K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 282 253 $32K
82784 3,699 3,176 $31K
86200 3,432 3,029 $31K
82950 7,768 7,098 $30K
83690 5,789 5,181 $29K
83013 897 816 $29K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,377 1,252 $28K
85610 9,563 7,229 $27K
82627 2,272 1,969 $26K
86160 1,949 1,770 $26K
82550 6,406 5,478 $25K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 541 502 $25K
82533 2,205 1,935 $24K
84480 2,657 2,299 $22K
87205 7,620 6,889 $22K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 331 260 $21K
82951 1,964 1,800 $21K
86704 1,781 1,580 $21K
86735 1,731 1,519 $19K
88312 366 323 $19K
86850 3,337 3,009 $19K
87631 254 207 $18K
86141 1,366 1,073 $18K
82105 1,330 1,251 $18K
83516 1,890 1,573 $17K
84436 3,301 2,965 $16K
84466 1,845 1,682 $16K
85730 3,574 3,164 $16K
87493 482 439 $14K
86765 1,826 1,606 $14K
82274 1,442 1,338 $14K
84681 983 925 $14K
83721 2,648 2,374 $14K
86364 1,945 1,613 $13K
84100 4,764 3,741 $13K
84156 5,800 5,151 $13K
84703 2,020 1,785 $13K
83020 1,458 1,314 $13K
80069 2,823 2,502 $12K
87653 366 347 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 421 392 $12K
87338 830 733 $12K
86039 1,326 1,193 $12K
86901 3,515 3,140 $11K
82652 746 634 $11K
83525 1,187 1,068 $11K
86336 572 545 $10K
82150 2,155 1,898 $10K
86694 900 786 $10K
86592 3,010 2,624 $10K
86255 1,481 1,225 $10K
87328 852 777 $10K
84460 2,955 2,715 $9K
87045 1,125 1,011 $9K
86618 675 614 $9K
85379 1,289 1,124 $9K
88341 133 113 $8K
86900 3,113 2,784 $8K
80164 1,543 1,359 $8K
86677 853 706 $8K
83615 1,941 1,592 $8K
84165 1,181 1,071 $8K
82677 562 537 $7K
87210 1,784 1,611 $7K
83520 660 582 $7K
86334 502 467 $7K
87147 2,037 1,843 $7K
87329 831 755 $7K
85007 2,359 2,148 $6K
87046 1,150 1,029 $6K
86147 227 207 $6K
80177 740 655 $6K
87075 858 773 $5K
84134 500 457 $5K
82947 1,795 1,633 $5K
84432 376 350 $5K
88304 224 197 $5K
82952 1,346 1,235 $4K
80055 99 92 $4K
85044 1,457 1,327 $4K
82248 1,313 1,125 $4K
87641 124 120 $4K
86812 256 232 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 97 87 $4K
86708 405 341 $3K
82977 766 666 $3K
86231 432 392 $3K
82378 361 315 $3K
82747 258 235 $3K
80178 699 607 $3K
82330 305 271 $3K
84450 796 730 $3K
84484 290 276 $3K
82565 814 710 $3K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 1,697 958 $2K
86304 149 131 $2K
82140 258 199 $2K
85520 250 233 $2K
88112 101 93 $2K
83993 183 171 $2K
86060 331 301 $2K
81025 287 219 $2K
85660 401 378 $2K
G0475 Hiv antigen/antibody, combination assay, screening 270 174 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 1,358 1,300 $1K
84154 116 109 $1K
86593 390 343 $1K
86256 96 88 $1K
85613 174 163 $1K
84155 589 542 $1K
82465 361 331 $1K
85670 246 231 $1K
86146 31 27 $1K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 753 687 $1K
85732 159 150 $975.79
86665 41 38 $917.28
84132 260 244 $839.56
82310 173 147 $633.51
80349 41 31 $607.16
86705 48 37 $548.84
86308 143 138 $535.07
86300 27 25 $413.82
84520 133 115 $385.65
87076 60 53 $385.58
86880 88 83 $363.43
82040 110 100 $343.41
86015 45 37 $302.73
84479 93 82 $300.72
84425 42 41 $289.37
87106 39 38 $281.92
83090 24 24 $277.46
82085 39 36 $227.92
86361 13 12 $203.01
86778 13 12 $170.61
87420 12 12 $159.94
87206 53 42 $153.41
87324 15 15 $150.79
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 12 12 $140.78
82390 18 17 $134.06
87185 33 31 $111.55
87800 12 12 $87.25
82340 16 12 $73.76
0753T 388 288 $68.70
85014 88 76 $56.09
82247 59 51 $51.54
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 55 51 $6.88
0760T 81 63 $4.80